Purposes of the Meeting
- To receive the annual report of management, the audited consolidated financial statements of the Corporation for the financial year ended
March 31, 2021 and the independent auditor’s report thereon; - To elect the directors of the Corporation;
- To reappoint
Raymond Chabot Grant Thornton, LLP , as independent auditor of the Corporation for the ensuing year and to authorize the directors to fix its remuneration; - To approve by ordinary resolution the amendment to the Corporation’s existing stock option plan to increase the maximum number of common shares that may be issued pursuant thereto, from 9,000,000 to 10,200,000, as approved by the Board of directors on
August 10 th, 2021; and - To transact such other business as may properly come before the Meeting or any adjournment thereof.
The Corporation is strongly recommending all shareholders to vote by proxy in advance of the Meeting.
Attendance / participation at the Meeting
Due to COVID-19 sanitary measures, Registered Shareholders and Non-registered Holders (as defined in the Management Information Circular available on www.sedar.com) who do not intend to vote at the Meeting are kindly asked to participate via videoconferencing using this link; https://meet.google.com/bss-ebhp-pmm.
Only Registered Shareholders and duly appointed proxyholders who intend to vote at the Meeting will be able to attend the Meeting in person at the Corporation’s head office located at
About
Additional information is available at www.diagnos.com and www.sedar.com
This news release contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements.
Neither the
For further information, please contact: Mr.Marc-André Massue , CFO and SecretaryDIAGNOS Inc. Tel: 450-678-8882 ext. 235
Source:
2021 GlobeNewswire, Inc., source